About Actimis
Actimis is a company based in San Diego (United States) founded in 2004 was acquired by Boehringer Ingelheim in June 2008.. Actimis has raised $15.6 million across 2 funding rounds from investors including Boehringer Ingelheim, Sanderling Ventures and Mitsui Ventures.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.6 M (USD)
in 2 rounds
-
Latest Funding Round
$9.6 M (USD), Series B
Jun 06, 2008
-
Investors
Boehringer Ingelheim
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Boehringer Ingelheim
(Jun 17, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Actimis
Actimis has successfully raised a total of $15.6M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9.6 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $9.6M
-
First Round
First Round
(28 Apr 2005)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2008 | Amount | Series B - Actimis | Valuation |
investors |
|
| Apr, 2005 | Amount | Series A - Actimis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Actimis
Actimis has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Boehringer Ingelheim, Sanderling Ventures and Mitsui Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Generic drugs and clinical research services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Actimis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Actimis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Actimis Comparisons
Competitors of Actimis
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Actimis
When was Actimis founded?
Actimis was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Where is Actimis located?
Actimis is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Actimis a funded company?
Actimis is a funded company, having raised a total of $15.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Apr 28, 2005.
What does Actimis do?
Actimis Pharmaceuticals is a privately held biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease, inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. Actimis was spun off from Bayer Healthcare AG in November 2004. It got acquired by Boehringer-Ingelheim in 2008.
Who are Actimis's investors?
Actimis has 3 investors. Key investors include Boehringer Ingelheim, Sanderling Ventures, and Mitsui Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.